Similar articles

• [YEAR IN REVIEW OF NASAL ALLERGY: SUBLINGUAL IMMUNOTHERAPY].

  Masuyama K. Masuyama K. Arerugi. 2015 Sep;64(9):1210-4. doi: 10.15036/arerugi.64.1210. Arerugi. 2015. PMID: 26657909 Review. Japanese. No abstract available.
• Sublingual immunotherapy in children: the recent experiences.

  Pleskovic N, Bartholow A, Skoner DP. Pleskovic N, et al. Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):582-90. doi: 10.1097/ACI.0000000000000112. Curr Opin Allergy Clin Immunol. 2014. PMID: 25188717 Review.
• Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.

  Aydogan M, Eifan AO, Keles S, Akkoc T, Nursoy MA, Bahceciler NN, Barlan IB. Aydogan M, et al. Respir Med. 2013 Sep;107(9):1322-9. doi: 10.1016/j.rmed.2013.06.021. Epub 2013 Jul 23. Respir Med. 2013. PMID: 23886432 Clinical Trial.
• [SUBLINGUAL IMMUNOTHERAPY].

  Gotoh M. Gotoh M. Arerugi. 2015 Aug;64(8):1136-40. doi: 10.15036/arerugi.64.1136. Arerugi. 2015. PMID: 26522415 Japanese. No abstract available.
• Clinical Applications of Sublingual Immunotherapy.

  Edwards TS, Wise SK. Edwards TS, et al. Otolaryngol Clin North Am. 2017 Dec;50(6):1121-1134. doi: 10.1016/j.otc.2017.08.010. Otolaryngol Clin North Am. 2017. PMID: 29103453 Review.